Direct Costs of Asthma in a Referral Public Children's Hospital in Tehran, Iran
AbstractAsthma is one of the most common chronic diseases all over the world, which impacts socioeconomics of families and health care systems. We need to estimate the costs of asthma to set health policies and structural adjustments to control burden of asthma in societies. The aim of present study was to evaluate direct costs of asthma in children in Tehran-Iran. In a descriptive-analytical study, 100 children who were referred to Children’s Medical Center of Tehran University of Medical sciences, from March 2014 to March 2015, were selected randomly and studied. In an interview with parents we evaluated direct costs of asthma including physician fees, admission fees, medication costs, costs of transportation, and others. In present study, 72 patients (72.0%) were male and 28 patients (28.0%) were female with mean age of 6.9±0.3 years old. Annual mean of direct costs of outpatient care were calculated 5,179,000±620,000 Rials (159.3±19$), and with considering the admission costs, direct medical expenditure were calculated 6,069,600±140,000 Rials (186.7±4$) throughout the year. Non-medical annual costs of asthma in children were calculated 4,439,700±437,540 Rials (136.6±13$) during 2014-2015 in Tehran-Iran. Based on findings of present study, total costs of asthma with the help of close physician follow ups and effective usage of medications has decreased in recent decades; furthermore, in our study, outpatient management costs which accounted for 85.5% of total direct costs of asthma in children, had the largest share of direct costs of asthma management.
References: 1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006 ;367(9524):1747-57. 2. Bradshaw D, Groenewald P, Laubscher R , Nannan N , Nojilana B , Norman R , et al.Initial burden of disease estimates for South Africa, 2000. S Afr Med J. 2003 Sep;93(9):682-8. 3. Beyhun NE, Soyer OU, Kuyucu S, Sapan N, Altintaş DU, Yüksel H, et al. A multi-center survey of childhood asthma in Turke--I: the cost and its determinants. Pediatric allergy and immunology: official publication of the European Society of Pediatric Allergy and Immunology. 2009 Feb;20(1):72. 4. Moreira P, Moreira A, Padrão P, Delgado L. The role of economic and educational factors in asthma: evidence from the Portuguese healthsurvey. Public Health. 2008 Apr;122(4):434-9. 5. Park YS, Kim JH, Jang HJ, Tae YH, Lim DH. The effect of Asian dust on asthma by socioeconomic status using national health insuranceclaims data in Korea. Inhal Toxicol. 2016;28(1):1-6 6. Barnett SB, Nurmagambetov TA. Costs of asthma in the United States: 2002-2007. J Allergy Clin Immunol. 2011 Jan;127(1):145-52. 7. Kamble S, Bharmal M. Incremental direct expenditure of treating asthma in the United States. J Asthma. 2009 Feb;46(1):73-80. 8. Sharifi L, Dashti R, Pourpak Z, Fazlollahi MR, Movahedi M, Chavoshzadeh Z,et al. Economic Burden of Pediatric Asthma: Annual Cost of Disease in Iran. Iranian journal of public health. 2018 Feb;47(2):256. 9. Weiss KB, Sullivan SD. Understanding the costs of asthma: the next step CMAJ. 1996 Mar 15;154(6):841-3.